Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




U.S. Medicare to Tighten Rules for Private Plans
Link ID 5607
Title U.S. Medicare to Tighten Rules for Private Plans
Url http://www.medscape.com/viewarticle/574250?src=rss
Description Companies that sell Medicare Advantage plans would have to modify sales commissions to stop salesmen from switching beneficiaries to a new plan each year to earn the highest possible fee, a U.S. government agency proposed on Thursday. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date May 10, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Quality of Care in Our Hospitals: Paradoxes, Branding, and Leadership
  NMA 2007: Regardless of where your hospital stood yesterday, tomorrow it will be judged by new standards of quality measures.
Medscape Internal Medicine
Category:   Articles > Business of Medicine


2. Recentin Fails Lung Cancer Trial
  A clinical trial of Recentin as a treatment for non-small-cell lung cancer has been halted by AstraZeneca, Plc, after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead. Reuters Health Information
Category:   Articles > Business of Medicine


3. How Can I Avoid Clinical Mistakes?
  I am constantly worrying about making mistakes. Is there any way to minimize errors?
Medscape Med Students
Category:   Articles > Business of Medicine


4. How Should the APN Code for a Counseling Visit?
  As oncology nurse practitioners in a private practice, we have been asked to provide educational visits formerly done by the RNs. How should we code these counseling visits?
Medscape Nurses
Category:   Articles > Business of Medicine


5. AstraZeneca: FDA Extends Cancer Drug Patent by Six Months
  British drug maker AstraZeneca Plc said U.S. health regulators extended market exclusivity for its breast cancer drug, Arimidex, by six months. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS